Achaogen Inc. | Ownership
Companies that own Achaogen Inc.
SSgA Funds Management, Inc.
3,386,483
7.49%
283,454
0%
06/30/2018
BlackRock Fund Advisors
2,583,618
5.72%
-95,694
0%
06/30/2018
Fidelity Management & Research Co.
1,616,895
3.58%
-1,803,897
0%
06/30/2018
The Vanguard Group, Inc.
1,456,440
3.22%
26,208
0%
06/30/2018
TimesSquare Capital Management LLC
1,216,611
2.69%
-67,800
0.04%
06/30/2018
AXA Investment Managers UK Ltd.
687,436
1.52%
72,297
0.01%
06/30/2018
OZ Management LP
465,300
1.03%
270,400
0.03%
06/30/2018
Prosight Management LP
375,000
0.83%
-286,054
1.36%
06/30/2018
Northern Trust Investments, Inc.
372,221
0.82%
-3,907
0%
06/30/2018
Geode Capital Management LLC
333,606
0.74%
30,454
0%
06/30/2018
| Address |
1 Tower Place
South San Francisco California 94080
United States
|
|
Employees
|
- |
| Website |
http://www.achaogen.com |
| Updated |
09/14/2018 |
| Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections. It offers Plazomicin to treat bacterial illness, such as complicated urinary tract infection, blood stream infections, and other infections due to MDR Enterobacteriaceae. The company was founded by Nathaniel E. |
